The latest news on Ike Davis’ ankle injury isn’t good.
He got a cortisone shot yesterday and is slated to undergo an MRI exam over the weekend, with season-ending surgery looming if he doesn’t show significant improvement.
I wouldn’t say pessimistic, but I would say in three weeks, by the rule of the injury, if I’m not taking steps to play in three weeks, there’s something structurally wrong. If I could avoid surgery–surgery is not fun and sometimes stuff doesn’t feel the same after. And I’m trying to do as much as I can, the cortisone shot is like a last-ditch effort to see if we can push forward without having the surgery.
What makes the multiple setbacks Davis has experienced all the more frustrating is that he was off to a great start, following up an impressive rookie season by hitting .302 with seven homers and a .925 OPS through 36 games. Daniel Murphy and Lucas Duda haven’t been able to come close to that production and in his lengthy absence the Mets have slipped to the middle of the pack in overall OPS at first base for the season.